Increasing Access to Fertility Preservation for Women with Breast Cancer
Recruiting now · Not applicable
Conditions studied: Breast Cancer
In brief
The EVAPREF project aims to increase access to fertility preservation by developing an approach to improve and evaluate existing information and coordination tools developed by the Pays-de-la-Loire and Occitanie Regional Cancer networks. First, the investigators will use a qualitative, iterative, user-centered and participatory approach to improve the current tools and create training content for the physicians who will use these tools. Second, the investigators will conduct a randomized stepped wedge trial of women under 40 newly treated with chemotherapy for breast cancer. The investigators will evaluate the rate of fertility preservation consultation before and after implementation of the improved tools, over a 30-month period from mid-2023 to the end of 2025. Finally, in a third step, the investigators will study their approach (context-sensitive implementation analysis) and provide key elements for its transferability to other contexts and in particular to other Regional Cancer networks in France.
Key facts
- Study ID
- NCT05989776
- Run by
- University Paul Sabatier of Toulouse
- People needed
- 750
- Starts
- 2022-06-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2024-12-12
Who can join
Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients over 18 and under 40 years of age treated for newly diagnosed breast cancer and receiving chemotherapy.
- People who are able to read the study information poster and the fertility preservation information brochure in French, either alone or with help from a caregiver or relative or an interpreter.
- People with intellectual disability will be included as long as they are able able to read the study information poster and the fertility preservation information brochure in French alone or with help from a caregiver or relative or an interpreter..
You may not qualify if…
- People whose mental health status precludes participation in the study, as determined by the clinical team.
Where it is running
- CHU Nantes — Nantes, France (enrolling)
- Institut Claudius Regaud (IUCT-O) — Toulouse, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.